Chester County News and Community Website
WASHINGTON, D.C. — The Food and Drug Administration (FDA) recently granted accelerated approval for a new treatment combination for adults with KRAS G12C-mutated locally advanced or metastatic colorectal cancer (CRC). …
FDA Grants Accelerated Approval to New Colorectal Cancer Treatment Read More
WASHINGTON, D.C. — On Monday, the Food and Drug Administration (FDA) approved pembrolizumab (Keytruda, Merck) in combination with carboplatin and paclitaxel, followed by single-agent pembrolizumab, for adult patients with primary …
FDA Approves Keytruda Combination for Advanced Endometrial Cancer Read More
WASHINGTON, D.C. — On Friday, the Food and Drug Administration (FDA) approved durvalumab (Imfinzi, AstraZeneca UK Limited) for use with carboplatin plus paclitaxel followed by single-agent durvalumab. This approval targets …
FDA Approves New Treatment for Advanced Endometrial Cancer Read More WASHINGTON, D.C. — On Friday, the Food and Drug Administration (FDA) approved blinatumomab (Blincyto, Amgen Inc.) for both adult and pediatric patients one month and older with CD19-positive Philadelphia chromosome-negative …
FDA Approves Blinatumomab for Advanced Leukemia Treatment Read More
PLYMOUTH MEETING, PA — New research published in the June 2024 issue of the Journal of the National Comprehensive Cancer Network (JNCCN) highlights a promising approach to improving the well-being …
Positive Psychology Program Shows Promise for Blood Cancer Patients Post-Transplant Read More
WASHINGTON, D.C. — The FDA on Wednesday granted full approval to the drug selpercatinib, marketed as Retevmo, for treating advanced thyroid cancer in both adults and children aged 2 and …
FDA Grants Full Approval to Retevmo for Advanced Thyroid Cancer Read More
LANGHORNE, PA — Biomarker testing for patients with non-small cell lung cancer (NSCLC) in the United States is significantly underutilized, according to a study by Amplity Health. Presented at the …
Amplity Health Study Reveals Underutilization of Biomarker Testing in Lung Cancer Treatment Read More
PHILADELPHIA, PA — Advanced clear cell renal cell carcinoma (ccRCC) is a formidable form of kidney cancer, causing an alarming mortality rate as even recent immunotherapies leave survival chances in …
New Hope for Tough Kidney Cancer: Reinventing Antibody Therapies Read More
DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) announced a significant development in its ongoing ABOYA-119 clinical trial. The Safety Review Committee (SRC) has approved the commencement of dosing patients …
Aprea Therapeutics Advances Cancer Treatment Trial to Higher Dose Level Read More PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network (NCCN) has published new guidelines for patients facing small bowel adenocarcinoma. This rare cancer type occurs in the small intestine, an …
New Patient Guidelines Released for Rare Small Bowel Cancer Read More